TNXP
Tonix Pharmaceuticals Holding Corp
Price:  
1.15 
USD
Volume:  
6,612,819.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TNXP Fair Value

-548.71 %
Upside

As of 2024-06-15, the Fair Value of Tonix Pharmaceuticals Holding Corp (TNXP) is -5.16 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.15 USD, the upside of Tonix Pharmaceuticals Holding Corp is -548.71%.

Note: valuation result may not be accurate due to the company's negative EPS.

1.15 USD
Stock Price
-5.16 USD
Fair Price
FAIR VALUE CALCULATION

TNXP Fair Value

Peter Lynch's formula is:

TNXP Fair Value
= Earnings Growth Rate x TTM EPS
TNXP Fair Value
= 5.00 x -1.03
TNXP Fair Value
= -5.16

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -28.62 -50.46 -92.29 -110.22 -116.66 -79.65
YoY growth -9.70% -76.31% -82.90% -19.43% -5.84% -38.83%

TNXP Fair Value - Key Data

Market Cap (mil) 9.93
P/E
Forward P/E
EPS -1.03
Avg earnings growth rate -38.83%
TTM earnings -98.60